Inovio Pharmaceuticals CMV Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study

News   Nov 28, 2012

 
Inovio Pharmaceuticals CMV Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
 
 
 

RELATED ARTICLES

Can Epigenetics Help Explain the Mechanisms of Autism?

News

New findings suggest that epigenetic analysis of DNA regions that control gene expression may hold clues to the genetic basis of autism spectrum disorder.

READ MORE

Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication

News

Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV).

READ MORE

Genetics of Mitochondrial Mutation Exposed

News

A study has revealed how fatal mitochondrial disease can appear unexpectedly in families without history of such diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE